Asia-Pacific Oncology/Anti-Cancer Drugs Market Report 2017

October 2017 | 105 pages | ID: A2BD7B6615DEN
QYResearch

Abstracts

In this report, the Asia-Pacific Oncology/Anti-Cancer Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Oncology/Anti-Cancer Drugs for these regions, from 2012 to 2022 (forecast), including

• China
• Japan
• South Korea
• Taiwan
• India
• Southeast Asia
• Australia

Asia-Pacific Oncology/Anti-Cancer Drugs market competition by top manufacturers/players, with Oncology/Anti-Cancer Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Amgen
• AstraZeneca
• Roche Diagnostics
• GlaxoSmithKline
• Merck
• Novartis
• AbbVie
• Sanofi
• EIMC United Pharmaceuticals
• Actavis

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into

• Chemotherapy
• Targeted Therapy
• Immunotherapy (Biologic Therapy)
• Hormonal Therapy
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Oncology/Anti-Cancer Drugs for each application, includin

• Blood Cancer (Leukaemia)
• Breast Cancer
• Gastrointestinal Cancer
• Respiratory/Lung Cancer
• Skin Cancer
• Other Cancers

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Asia-Pacific Oncology/Anti-Cancer Drugs Market Report 2017

1 ONCOLOGY/ANTI-CANCER DRUGS OVERVIEW

1.1 Product Overview and Scope of Oncology/Anti-Cancer Drugs
1.2 Classification of Oncology/Anti-Cancer Drugs by Product Category
  1.2.1 Asia-Pacific Oncology/Anti-Cancer Drugs Market Size (Sales) Comparison by Types (2012-2022)
  1.2.2 Asia-Pacific Oncology/Anti-Cancer Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Chemotherapy
  1.2.4 Targeted Therapy
  1.2.5 Immunotherapy (Biologic Therapy)
  1.2.6 Hormonal Therapy
  1.2.7 Others
1.3 Asia-Pacific Oncology/Anti-Cancer Drugs Market by Application/End Users
  1.3.1 Asia-Pacific Oncology/Anti-Cancer Drugs Sales (Volume) and Market Share Comparison by Applications (2012-2022)
  1.3.2 Blood Cancer (Leukaemia)
  1.3.3 Breast Cancer
  1.3.4 Gastrointestinal Cancer
  1.3.5 Respiratory/Lung Cancer
  1.3.6 Skin Cancer
  1.3.7 Other Cancers
1.4 Asia-Pacific Oncology/Anti-Cancer Drugs Market by Region
  1.4.1 Asia-Pacific Oncology/Anti-Cancer Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 China Status and Prospect (2012-2022)
  1.4.3 Japan Status and Prospect (2012-2022)
  1.4.4 South Korea Status and Prospect (2012-2022)
  1.4.5 Taiwan Status and Prospect (2012-2022)
  1.4.6 India Status and Prospect (2012-2022)
  1.4.7 Southeast Asia Status and Prospect (2012-2022)
  1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of Oncology/Anti-Cancer Drugs (2012-2022)
  1.5.1 Asia-Pacific Oncology/Anti-Cancer Drugs Sales and Growth Rate (2012-2022)
  1.5.2 Asia-Pacific Oncology/Anti-Cancer Drugs Revenue and Growth Rate (2012-2022)

2 ASIA-PACIFIC ONCOLOGY/ANTI-CANCER DRUGS COMPETITION BY PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 Asia-Pacific Oncology/Anti-Cancer Drugs Market Competition by Players/Suppliers
  2.1.1 Asia-Pacific Oncology/Anti-Cancer Drugs Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Asia-Pacific Oncology/Anti-Cancer Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific Oncology/Anti-Cancer Drugs (Volume and Value) by Type
  2.2.1 Asia-Pacific Oncology/Anti-Cancer Drugs Sales and Market Share by Type (2012-2017)
  2.2.2 Asia-Pacific Oncology/Anti-Cancer Drugs Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific Oncology/Anti-Cancer Drugs (Volume) by Application
2.4 Asia-Pacific Oncology/Anti-Cancer Drugs (Volume and Value) by Region
  2.4.1 Asia-Pacific Oncology/Anti-Cancer Drugs Sales and Market Share by Region (2012-2017)
  2.4.2 Asia-Pacific Oncology/Anti-Cancer Drugs Revenue and Market Share by Region (2012-2017)

3 CHINA ONCOLOGY/ANTI-CANCER DRUGS (VOLUME, VALUE AND SALES PRICE)

3.1 China Oncology/Anti-Cancer Drugs Sales and Value (2012-2017)
  3.1.1 China Oncology/Anti-Cancer Drugs Sales Volume and Growth Rate (2012-2017)
  3.1.2 China Oncology/Anti-Cancer Drugs Revenue and Growth Rate (2012-2017)
  3.1.3 China Oncology/Anti-Cancer Drugs Sales Price Trend (2012-2017)
3.2 China Oncology/Anti-Cancer Drugs Sales Volume and Market Share by Type
3.3 China Oncology/Anti-Cancer Drugs Sales Volume and Market Share by Application

4 JAPAN ONCOLOGY/ANTI-CANCER DRUGS (VOLUME, VALUE AND SALES PRICE)

4.1 Japan Oncology/Anti-Cancer Drugs Sales and Value (2012-2017)
  4.1.1 Japan Oncology/Anti-Cancer Drugs Sales Volume and Growth Rate (2012-2017)
  4.1.2 Japan Oncology/Anti-Cancer Drugs Revenue and Growth Rate (2012-2017)
  4.1.3 Japan Oncology/Anti-Cancer Drugs Sales Price Trend (2012-2017)
4.2 Japan Oncology/Anti-Cancer Drugs Sales Volume and Market Share by Type
4.3 Japan Oncology/Anti-Cancer Drugs Sales Volume and Market Share by Application

5 SOUTH KOREA ONCOLOGY/ANTI-CANCER DRUGS (VOLUME, VALUE AND SALES PRICE)

5.1 South Korea Oncology/Anti-Cancer Drugs Sales and Value (2012-2017)
  5.1.1 South Korea Oncology/Anti-Cancer Drugs Sales Volume and Growth Rate (2012-2017)
  5.1.2 South Korea Oncology/Anti-Cancer Drugs Revenue and Growth Rate (2012-2017)
  5.1.3 South Korea Oncology/Anti-Cancer Drugs Sales Price Trend (2012-2017)
5.2 South Korea Oncology/Anti-Cancer Drugs Sales Volume and Market Share by Type
5.3 South Korea Oncology/Anti-Cancer Drugs Sales Volume and Market Share by Application

6 TAIWAN ONCOLOGY/ANTI-CANCER DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 Taiwan Oncology/Anti-Cancer Drugs Sales and Value (2012-2017)
  6.1.1 Taiwan Oncology/Anti-Cancer Drugs Sales Volume and Growth Rate (2012-2017)
  6.1.2 Taiwan Oncology/Anti-Cancer Drugs Revenue and Growth Rate (2012-2017)
  6.1.3 Taiwan Oncology/Anti-Cancer Drugs Sales Price Trend (2012-2017)
6.2 Taiwan Oncology/Anti-Cancer Drugs Sales Volume and Market Share by Type
6.3 Taiwan Oncology/Anti-Cancer Drugs Sales Volume and Market Share by Application

7 INDIA ONCOLOGY/ANTI-CANCER DRUGS (VOLUME, VALUE AND SALES PRICE)

7.1 India Oncology/Anti-Cancer Drugs Sales and Value (2012-2017)
  7.1.1 India Oncology/Anti-Cancer Drugs Sales Volume and Growth Rate (2012-2017)
  7.1.2 India Oncology/Anti-Cancer Drugs Revenue and Growth Rate (2012-2017)
  7.1.3 India Oncology/Anti-Cancer Drugs Sales Price Trend (2012-2017)
7.2 India Oncology/Anti-Cancer Drugs Sales Volume and Market Share by Type
7.3 India Oncology/Anti-Cancer Drugs Sales Volume and Market Share by Application

8 SOUTHEAST ASIA ONCOLOGY/ANTI-CANCER DRUGS (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia Oncology/Anti-Cancer Drugs Sales and Value (2012-2017)
  8.1.1 Southeast Asia Oncology/Anti-Cancer Drugs Sales Volume and Growth Rate (2012-2017)
  8.1.2 Southeast Asia Oncology/Anti-Cancer Drugs Revenue and Growth Rate (2012-2017)
  8.1.3 Southeast Asia Oncology/Anti-Cancer Drugs Sales Price Trend (2012-2017)
8.2 Southeast Asia Oncology/Anti-Cancer Drugs Sales Volume and Market Share by Type
8.3 Southeast Asia Oncology/Anti-Cancer Drugs Sales Volume and Market Share by Application

9 AUSTRALIA ONCOLOGY/ANTI-CANCER DRUGS (VOLUME, VALUE AND SALES PRICE)

9.1 Australia Oncology/Anti-Cancer Drugs Sales and Value (2012-2017)
  9.1.1 Australia Oncology/Anti-Cancer Drugs Sales Volume and Growth Rate (2012-2017)
  9.1.2 Australia Oncology/Anti-Cancer Drugs Revenue and Growth Rate (2012-2017)
  9.1.3 Australia Oncology/Anti-Cancer Drugs Sales Price Trend (2012-2017)
9.2 Australia Oncology/Anti-Cancer Drugs Sales Volume and Market Share by Type
9.3 Australia Oncology/Anti-Cancer Drugs Sales Volume and Market Share by Application

10 ASIA-PACIFIC ONCOLOGY/ANTI-CANCER DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

10.1 Amgen
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Oncology/Anti-Cancer Drugs Product Category, Application and Specification
    10.1.2.1 Product A
    10.1.2.2 Product B
  10.1.3 Amgen Oncology/Anti-Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Main Business/Business Overview
10.2 AstraZeneca
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Oncology/Anti-Cancer Drugs Product Category, Application and Specification
    10.2.2.1 Product A
    10.2.2.2 Product B
  10.2.3 AstraZeneca Oncology/Anti-Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Main Business/Business Overview
10.3 Roche Diagnostics
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Oncology/Anti-Cancer Drugs Product Category, Application and Specification
    10.3.2.1 Product A
    10.3.2.2 Product B
  10.3.3 Roche Diagnostics Oncology/Anti-Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Main Business/Business Overview
10.4 GlaxoSmithKline
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Oncology/Anti-Cancer Drugs Product Category, Application and Specification
    10.4.2.1 Product A
    10.4.2.2 Product B
  10.4.3 GlaxoSmithKline Oncology/Anti-Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Main Business/Business Overview
10.5 Merck
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Oncology/Anti-Cancer Drugs Product Category, Application and Specification
    10.5.2.1 Product A
    10.5.2.2 Product B
  10.5.3 Merck Oncology/Anti-Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Main Business/Business Overview
10.6 Novartis
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Oncology/Anti-Cancer Drugs Product Category, Application and Specification
    10.6.2.1 Product A
    10.6.2.2 Product B
  10.6.3 Novartis Oncology/Anti-Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Main Business/Business Overview
10.7 AbbVie
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Oncology/Anti-Cancer Drugs Product Category, Application and Specification
    10.7.2.1 Product A
    10.7.2.2 Product B
  10.7.3 AbbVie Oncology/Anti-Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Main Business/Business Overview
10.8 Sanofi
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Oncology/Anti-Cancer Drugs Product Category, Application and Specification
    10.8.2.1 Product A
    10.8.2.2 Product B
  10.8.3 Sanofi Oncology/Anti-Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Main Business/Business Overview
10.9 EIMC United Pharmaceuticals
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Oncology/Anti-Cancer Drugs Product Category, Application and Specification
    10.9.2.1 Product A
    10.9.2.2 Product B
  10.9.3 EIMC United Pharmaceuticals Oncology/Anti-Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Main Business/Business Overview
10.10 Actavis
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Oncology/Anti-Cancer Drugs Product Category, Application and Specification
    10.10.2.1 Product A
    10.10.2.2 Product B
  10.10.3 Actavis Oncology/Anti-Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.10.4 Main Business/Business Overview

11 ONCOLOGY/ANTI-CANCER DRUGS MANUFACTURING COST ANALYSIS

11.1 Oncology/Anti-Cancer Drugs Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Oncology/Anti-Cancer Drugs

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Oncology/Anti-Cancer Drugs Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Oncology/Anti-Cancer Drugs Major Manufacturers in 2016
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 ASIA-PACIFIC ONCOLOGY/ANTI-CANCER DRUGS MARKET FORECAST (2017-2022)

15.1 Asia-Pacific Oncology/Anti-Cancer Drugs Sales Volume, Revenue and Price Forecast (2017-2022)
  15.1.1 Asia-Pacific Oncology/Anti-Cancer Drugs Sales Volume and Growth Rate Forecast (2017-2022)
  15.1.2 Asia-Pacific Oncology/Anti-Cancer Drugs Revenue and Growth Rate Forecast (2017-2022)
  15.1.3 Asia-Pacific Oncology/Anti-Cancer Drugs Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific Oncology/Anti-Cancer Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.1 Asia-Pacific Oncology/Anti-Cancer Drugs Sales Volume and Growth Rate Forecast by Region (2017-2022)
  15.2.2 Asia-Pacific Oncology/Anti-Cancer Drugs Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.3 China Oncology/Anti-Cancer Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.4 Japan Oncology/Anti-Cancer Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.5 South Korea Oncology/Anti-Cancer Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.6 Taiwan Oncology/Anti-Cancer Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.7 India Oncology/Anti-Cancer Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.8 Southeast Asia Oncology/Anti-Cancer Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.9 Australia Oncology/Anti-Cancer Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific Oncology/Anti-Cancer Drugs Sales, Revenue and Price Forecast by Type (2017-2022)
  15.3.1 Asia-Pacific Oncology/Anti-Cancer Drugs Sales Forecast by Type (2017-2022)
  15.3.2 Asia-Pacific Oncology/Anti-Cancer Drugs Revenue Forecast by Type (2017-2022)
  15.3.3 Asia-Pacific Oncology/Anti-Cancer Drugs Price Forecast by Type (2017-2022)
15.4 Asia-Pacific Oncology/Anti-Cancer Drugs Sales Forecast by Application (2017-2022)

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology/Research Approach
  17.1.1 Research Programs/Design
  17.1.2 Market Size Estimation
  17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
  17.2.1 Secondary Sources
  17.2.2 Primary Sources
17.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Oncology/Anti-Cancer Drugs
Figure Asia-Pacific Oncology/Anti-Cancer Drugs Sales Volume (K Units) by Type (2012-2022)
Figure Asia-Pacific Oncology/Anti-Cancer Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Chemotherapy Product Picture
Figure Targeted Therapy Product Picture
Figure Immunotherapy (Biologic Therapy) Product Picture
Figure Hormonal Therapy Product Picture
Figure Others Product Picture
Figure Asia-Pacific Oncology/Anti-Cancer Drugs Sales (K Units) by Application (2012-2022)
Figure Asia-Pacific Sales Market Share of Oncology/Anti-Cancer Drugs by Application in 2016
Figure Blood Cancer (Leukaemia) Examples
Table Key Downstream Customer in Blood Cancer (Leukaemia)
Figure Breast Cancer Examples
Table Key Downstream Customer in Breast Cancer
Figure Gastrointestinal Cancer Examples
Table Key Downstream Customer in Gastrointestinal Cancer
Figure Respiratory/Lung Cancer Examples
Table Key Downstream Customer in Respiratory/Lung Cancer
Figure Skin Cancer Examples
Table Key Downstream Customer in Skin Cancer
Figure Other Cancers Examples
Table Key Downstream Customer in Other Cancers
Figure Asia-Pacific Oncology/Anti-Cancer Drugs Market Size (Million USD) by Region (2012-2022)
Figure China Oncology/Anti-Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Oncology/Anti-Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure South Korea Oncology/Anti-Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Taiwan Oncology/Anti-Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Oncology/Anti-Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Oncology/Anti-Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Australia Oncology/Anti-Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Oncology/Anti-Cancer Drugs Sales Volume (K Units) and Growth Rate (2012-2022)
Figure Asia-Pacific Oncology/Anti-Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Oncology/Anti-Cancer Drugs Market Major Players Product Sales Volume (K Units)(2012-2017)
Table Asia-Pacific Oncology/Anti-Cancer Drugs Sales (K Units) of Key Players/Suppliers (2012-2017)
Table Asia-Pacific Oncology/Anti-Cancer Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Oncology/Anti-Cancer Drugs Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Oncology/Anti-Cancer Drugs Sales Share by Players/Suppliers
Figure Asia-Pacific Oncology/Anti-Cancer Drugs Market Major Players Product Revenue (Million USD) 2012-2017
Table Asia-Pacific Oncology/Anti-Cancer Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Asia-Pacific Oncology/Anti-Cancer Drugs Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Oncology/Anti-Cancer Drugs Revenue Share by Players
Figure 2017 Asia-Pacific Oncology/Anti-Cancer Drugs Revenue Share by Players
Table Asia-Pacific Oncology/Anti-Cancer Drugs Sales and Market Share by Type (2012-2017)
Table Asia-Pacific Oncology/Anti-Cancer Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Oncology/Anti-Cancer Drugs by Type (2012-2017)
Figure Asia-Pacific Oncology/Anti-Cancer Drugs Sales Growth Rate by Type (2012-2017)
Table Asia-Pacific Oncology/Anti-Cancer Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table Asia-Pacific Oncology/Anti-Cancer Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Oncology/Anti-Cancer Drugs by Type (2012-2017)
Figure Asia-Pacific Oncology/Anti-Cancer Drugs Revenue Growth Rate by Type (2012-2017)
Table Asia-Pacific Oncology/Anti-Cancer Drugs Sales Volume (K Units) and Market Share by Region (2012-2017)
Table Asia-Pacific Oncology/Anti-Cancer Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Oncology/Anti-Cancer Drugs by Region (2012-2017)
Figure Asia-Pacific Oncology/Anti-Cancer Drugs Sales Market Share by Region in 2016
Table Asia-Pacific Oncology/Anti-Cancer Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table Asia-Pacific Oncology/Anti-Cancer Drugs Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Oncology/Anti-Cancer Drugs by Region (2012-2017)
Figure Asia-Pacific Oncology/Anti-Cancer Drugs Revenue Market Share by Region in 2016
Table Asia-Pacific Oncology/Anti-Cancer Drugs Sales Volume (K Units) and Market Share by Application (2012-2017)
Table Asia-Pacific Oncology/Anti-Cancer Drugs Sales Share (%) by Application (2012-2017)
Figure Asia-Pacific Oncology/Anti-Cancer Drugs Sales Market Share by Application (2012-2017)
Figure Asia-Pacific Oncology/Anti-Cancer Drugs Sales Market Share by Application (2012-2017)
Figure China Oncology/Anti-Cancer Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure China Oncology/Anti-Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Oncology/Anti-Cancer Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table China Oncology/Anti-Cancer Drugs Sales Volume (K Units) by Type (2012-2017)
Table China Oncology/Anti-Cancer Drugs Sales Volume Market Share by Type (2012-2017)
Figure China Oncology/Anti-Cancer Drugs Sales Volume Market Share by Type in 2016
Table China Oncology/Anti-Cancer Drugs Sales Volume (K Units) by Applications (2012-2017)
Table China Oncology/Anti-Cancer Drugs Sales Volume Market Share by Application (2012-2017)
Figure China Oncology/Anti-Cancer Drugs Sales Volume Market Share by Application in 2016
Figure Japan Oncology/Anti-Cancer Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Japan Oncology/Anti-Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Oncology/Anti-Cancer Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table Japan Oncology/Anti-Cancer Drugs Sales Volume (K Units) by Type (2012-2017)
Table Japan Oncology/Anti-Cancer Drugs Sales Volume Market Share by Type (2012-2017)
Figure Japan Oncology/Anti-Cancer Drugs Sales Volume Market Share by Type in 2016
Table Japan Oncology/Anti-Cancer Drugs Sales Volume (K Units) by Applications (2012-2017)
Table Japan Oncology/Anti-Cancer Drugs Sales Volume Market Share by Application (2012-2017)
Figure Japan Oncology/Anti-Cancer Drugs Sales Volume Market Share by Application in 2016
Figure South Korea Oncology/Anti-Cancer Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure South Korea Oncology/Anti-Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure South Korea Oncology/Anti-Cancer Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table South Korea Oncology/Anti-Cancer Drugs Sales Volume (K Units) by Type (2012-2017)
Table South Korea Oncology/Anti-Cancer Drugs Sales Volume Market Share by Type (2012-2017)
Figure South Korea Oncology/Anti-Cancer Drugs Sales Volume Market Share by Type in 2016
Table South Korea Oncology/Anti-Cancer Drugs Sales Volume (K Units) by Applications (2012-2017)
Table South Korea Oncology/Anti-Cancer Drugs Sales Volume Market Share by Application (2012-2017)
Figure South Korea Oncology/Anti-Cancer Drugs Sales Volume Market Share by Application in 2016
Figure Taiwan Oncology/Anti-Cancer Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Taiwan Oncology/Anti-Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Taiwan Oncology/Anti-Cancer Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table Taiwan Oncology/Anti-Cancer Drugs Sales Volume (K Units) by Type (2012-2017)
Table Taiwan Oncology/Anti-Cancer Drugs Sales Volume Market Share by Type (2012-2017)
Figure Taiwan Oncology/Anti-Cancer Drugs Sales Volume Market Share by Type in 2016
Table Taiwan Oncology/Anti-Cancer Drugs Sales Volume (K Units) by Applications (2012-2017)
Table Taiwan Oncology/Anti-Cancer Drugs Sales Volume Market Share by Application (2012-2017)
Figure Taiwan Oncology/Anti-Cancer Drugs Sales Volume Market Share by Application in 2016
Figure India Oncology/Anti-Cancer Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure India Oncology/Anti-Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Oncology/Anti-Cancer Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table India Oncology/Anti-Cancer Drugs Sales Volume (K Units) by Type (2012-2017)
Table India Oncology/Anti-Cancer Drugs Sales Volume Market Share by Type (2012-2017)
Figure India Oncology/Anti-Cancer Drugs Sales Volume Market Share by Type in 2016
Table India Oncology/Anti-Cancer Drugs Sales Volume (K Units) by Application (2012-2017)
Table India Oncology/Anti-Cancer Drugs Sales Volume Market Share by Application (2012-2017)
Figure India Oncology/Anti-Cancer Drugs Sales Volume Market Share by Application in 2016
Figure Southeast Asia Oncology/Anti-Cancer Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Southeast Asia Oncology/Anti-Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Oncology/Anti-Cancer Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table Southeast Asia Oncology/Anti-Cancer Drugs Sales Volume (K Units) by Type (2012-2017)
Table Southeast Asia Oncology/Anti-Cancer Drugs Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Oncology/Anti-Cancer Drugs Sales Volume Market Share by Type in 2016
Table Southeast Asia Oncology/Anti-Cancer Drugs Sales Volume (K Units) by Applications (2012-2017)
Table Southeast Asia Oncology/Anti-Cancer Drugs Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Oncology/Anti-Cancer Drugs Sales Volume Market Share by Application in 2016
Figure Australia Oncology/Anti-Cancer Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Australia Oncology/Anti-Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Australia Oncology/Anti-Cancer Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table Australia Oncology/Anti-Cancer Drugs Sales Volume (K Units) by Type (2012-2017)
Table Australia Oncology/Anti-Cancer Drugs Sales Volume Market Share by Type (2012-2017)
Figure Australia Oncology/Anti-Cancer Drugs Sales Volume Market Share by Type in 2016
Table Australia Oncology/Anti-Cancer Drugs Sales Volume (K Units) by Applications (2012-2017)
Table Australia Oncology/Anti-Cancer Drugs Sales Volume Market Share by Application (2012-2017)
Figure Australia Oncology/Anti-Cancer Drugs Sales Volume Market Share by Application in 2016
Table Amgen Oncology/Anti-Cancer Drugs Basic Information List
Table Amgen Oncology/Anti-Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amgen Oncology/Anti-Cancer Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Amgen Oncology/Anti-Cancer Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Amgen Oncology/Anti-Cancer Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table AstraZeneca Oncology/Anti-Cancer Drugs Basic Information List
Table AstraZeneca Oncology/Anti-Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca Oncology/Anti-Cancer Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure AstraZeneca Oncology/Anti-Cancer Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure AstraZeneca Oncology/Anti-Cancer Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Roche Diagnostics Oncology/Anti-Cancer Drugs Basic Information List
Table Roche Diagnostics Oncology/Anti-Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Roche Diagnostics Oncology/Anti-Cancer Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Roche Diagnostics Oncology/Anti-Cancer Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Roche Diagnostics Oncology/Anti-Cancer Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table GlaxoSmithKline Oncology/Anti-Cancer Drugs Basic Information List
Table GlaxoSmithKline Oncology/Anti-Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Oncology/Anti-Cancer Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure GlaxoSmithKline Oncology/Anti-Cancer Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure GlaxoSmithKline Oncology/Anti-Cancer Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Merck Oncology/Anti-Cancer Drugs Basic Information List
Table Merck Oncology/Anti-Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Oncology/Anti-Cancer Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Merck Oncology/Anti-Cancer Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Merck Oncology/Anti-Cancer Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Novartis Oncology/Anti-Cancer Drugs Basic Information List
Table Novartis Oncology/Anti-Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis Oncology/Anti-Cancer Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Novartis Oncology/Anti-Cancer Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Novartis Oncology/Anti-Cancer Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table AbbVie Oncology/Anti-Cancer Drugs Basic Information List
Table AbbVie Oncology/Anti-Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AbbVie Oncology/Anti-Cancer Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure AbbVie Oncology/Anti-Cancer Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure AbbVie Oncology/Anti-Cancer Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Sanofi Oncology/Anti-Cancer Drugs Basic Information List
Table Sanofi Oncology/Anti-Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Oncology/Anti-Cancer Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Sanofi Oncology/Anti-Cancer Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Sanofi Oncology/Anti-Cancer Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table EIMC United Pharmaceuticals Oncology/Anti-Cancer Drugs Basic Information List
Table EIMC United Pharmaceuticals Oncology/Anti-Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure EIMC United Pharmaceuticals Oncology/Anti-Cancer Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure EIMC United Pharmaceuticals Oncology/Anti-Cancer Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure EIMC United Pharmaceuticals Oncology/Anti-Cancer Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Actavis Oncology/Anti-Cancer Drugs Basic Information List
Table Actavis Oncology/Anti-Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Actavis Oncology/Anti-Cancer Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Actavis Oncology/Anti-Cancer Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Actavis Oncology/Anti-Cancer Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Unit) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oncology/Anti-Cancer Drugs
Figure Manufacturing Process Analysis of Oncology/Anti-Cancer Drugs
Figure Oncology/Anti-Cancer Drugs Industrial Chain Analysis
Table Raw Materials Sources of Oncology/Anti-Cancer Drugs Major Manufacturers in 2016
Table Major Buyers of Oncology/Anti-Cancer Drugs
Table Distributors/Traders List
Figure Asia-Pacific Oncology/Anti-Cancer Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Oncology/Anti-Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Oncology/Anti-Cancer Drugs Price (USD/Unit) and Trend Forecast (2017-2022)
Table Asia-Pacific Oncology/Anti-Cancer Drugs Sales Volume (K Units) Forecast by Region (2017-2022)
Figure Asia-Pacific Oncology/Anti-Cancer Drugs Sales Volume Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Oncology/Anti-Cancer Drugs Sales Volume Market Share Forecast by Region in 2022
Table Asia-Pacific Oncology/Anti-Cancer Drugs Revenue (Million USD) Forecast by Region (2017-2022)
Figure Asia-Pacific Oncology/Anti-Cancer Drugs Revenue Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Oncology/Anti-Cancer Drugs Revenue Market Share Forecast by Region in 2022
Figure China Oncology/Anti-Cancer Drugs Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure China Oncology/Anti-Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Oncology/Anti-Cancer Drugs Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan Oncology/Anti-Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure South Korea Oncology/Anti-Cancer Drugs Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure South Korea Oncology/Anti-Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Taiwan Oncology/Anti-Cancer Drugs Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Taiwan Oncology/Anti-Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Oncology/Anti-Cancer Drugs Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure India Oncology/Anti-Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Oncology/Anti-Cancer Drugs Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Oncology/Anti-Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Australia Oncology/Anti-Cancer Drugs Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Australia Oncology/Anti-Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Asia-Pacific Oncology/Anti-Cancer Drugs Sales (K Units) Forecast by Type (2017-2022)
Figure Asia-Pacific Oncology/Anti-Cancer Drugs Sales Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Oncology/Anti-Cancer Drugs Revenue (Million USD) Forecast by Type (2017-2022)
Figure Asia-Pacific Oncology/Anti-Cancer Drugs Revenue Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Oncology/Anti-Cancer Drugs Price (USD/Unit) Forecast by Type (2017-2022)
Table Asia-Pacific Oncology/Anti-Cancer Drugs Sales (K Units) Forecast by Application (2017-2022)
Figure Asia-Pacific Oncology/Anti-Cancer Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources